QuidelOrtho Raised to Buy From Neutral by Citigroup
Citi Upgrades QuidelOrtho(QDEL.US) to Buy Rating, Raises Target Price to $50
RBC Capital Sticks to Their Buy Rating for QuidelOrtho (QDEL)
QuidelOrtho Initiated at Hold by Jefferies
QuidelOrtho Analyst Ratings
Jefferies Initiates QuidelOrtho(QDEL.US) With Hold Rating, Announces Target Price $43
Craig-Hallum Upgrades QuidelOrtho(QDEL.US) to Buy Rating, Raises Target Price to $60
J.P. Morgan Maintains QuidelOrtho(QDEL.US) With Sell Rating, Maintains Target Price $38
RBC Capital Maintains QuidelOrtho(QDEL.US) With Buy Rating, Raises Target Price to $64
RBC Capital Sticks to Its Buy Rating for QuidelOrtho (QDEL)
RBC Capital Maintains QuidelOrtho(QDEL.US) With Buy Rating, Raises Target Price to $62
RBC Capital Reaffirms Their Buy Rating on QuidelOrtho (QDEL)
QuidelOrtho Raised to Neutral From Sell by UBS
RBC Lifts Price Target on QuidelOrtho to $62 From $61, Keeps Outperform Rating
QuidelOrtho Analyst Ratings
Craig-Hallum Upgrades QuidelOrtho(QDEL.US) to Buy Rating, Raises Target Price to $57
QuidelOrtho Analyst Ratings
RBC Capital Maintains QuidelOrtho(QDEL.US) With Buy Rating, Maintains Target Price $61
RBC Capital Reaffirms Their Buy Rating on QuidelOrtho (QDEL)
QuidelOrtho Analyst Ratings